InnovAge (INNV) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
20 Mar, 2026Business model and market positioning
Delivers fully integrated, value-based care for high-acuity, dual-eligible seniors, enabling independent living and reducing nursing home admissions.
Operates the only scaled, multi-state PACE platform with advanced technology and operating capabilities.
Controls both payor and provider functions, assuming full risk for Medicare and Medicaid services, including supportive housing.
Serves over 8,000 participants across 20 centers in 6 states, with a $265B addressable market and 2.3M eligible lives.
Demonstrates consistent growth and profitability, supported by bipartisan policy tailwinds and a large, underpenetrated market.
Operational performance and financial results
Achieved a 12.7% revenue CAGR from 3QFY23 to 2QFY26, with revenues rising from $172.5M to $239.7M.
Adjusted EBITDA margin reached 9.2% in 2QFY26, with $58.9M in operating cash flow (TTM as of Dec 2025).
Center-level contribution margin expanded to 20.3% by 2QFY26, reflecting operational leverage and efficiency gains.
Fiscal 2026 guidance projects $925M–$950M in revenue and $70M–$75M in adjusted EBITDA.
Net income margin improved to 4.9% in 2QFY26, driven by insourcing, technology, and data-driven efficiencies.
Care model and outcomes
Provides comprehensive, interdisciplinary care with high patient engagement and a concierge PCP model.
Participants average >11 interdisciplinary team touchpoints and 2–7 center visits per month.
Achieves 10% lower inpatient admission rates and 40% lower 30-day readmission rates versus benchmarks.
Maintains voluntary disenrollment rates below 7%, less than half of Medicare Advantage rates.
Delivers 12% lower costs compared to similar Medicaid populations, with most participants remaining independent.
Latest events from InnovAge
- Q2 revenue and margins surged, raising full-year guidance despite ongoing cost and regulatory risks.INNV
Q2 20263 Feb 2026 - Care coordination, trust, and tailored technology are key to advancing aging-in-place models.INNV
7th Annual Healthcare Symposium3 Feb 2026 - Revenue up 11% with margin gains and positive Adjusted EBITDA; 2025 outlook remains strong.INNV
Q4 202421 Jan 2026 - Revenue up 12.4%, net loss halved, and Adjusted EBITDA margin improved to 3.2%.INNV
Q1 202516 Jan 2026 - Integrated care platform drives growth, margin expansion, and superior outcomes for complex seniors.INNV
44th Annual J.P. Morgan Healthcare Conference12 Jan 2026 - Revenue up 10.6% to $209M; FY2025 guidance reaffirmed amid margin and regulatory pressures.INNV
Q2 20259 Jan 2026 - Scale, technology, and insourcing drive growth and margin expansion in a supportive policy environment.INNV
KeyBanc Annual Health Care Forum 202526 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve officer exculpation amendment.INNV
Proxy Filing1 Dec 2025 - Director elections and auditor ratification headline a meeting focused on governance and oversight.INNV
Proxy Filing1 Dec 2025